{"id":452493,"date":"2021-03-08T08:03:30","date_gmt":"2021-03-08T13:03:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452493"},"modified":"2021-03-08T08:03:30","modified_gmt":"2021-03-08T13:03:30","slug":"chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/","title":{"rendered":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HAUPPAUGE, N.Y., March  08, 2021  (GLOBE NEWSWIRE) &#8212; Chembio Diagnostics, Inc. (Nasdaq:\u00a0CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company\u2019s Board of Directors, effective upon his election on March 4, 2021.<\/p>\n<p>Mr. Bespalko brings over 35 years of leadership experience in the global in vitro diagnostics market. Most recently he was Group Vice President, Global Commercial Operations Specialty Diagnostics Group at Thermo Fisher Scientific, which he joined in 2011 as President of Fisher Healthcare. During his tenure there, Mr. Bespalko held additional roles such as President of the Global Anatomical Pathology Division. Previously, Mr. Bespalko was Corporate Vice President, North America Commercial Operations at Beckman Coulter. His diagnostics career began in Canada with commercial and general management roles at Baxter Healthcare and Dade Behring. Mr. Bespalko now manages his own consulting firm, BMC, helping early-stage companies and providing executive mentorship.<\/p>\n<p align=\"left\">Also on March 4, 2021, Dr. Mary Lake Polan informed the Board of Directors that she would not stand for reelection to the Board at the Company\u2019s 2021 Annual Meeting of Shareholders.<\/p>\n<p align=\"left\">\u201cWe are delighted to welcome David to the Board of Directors,\u201d said Katherine L. Davis, Chair of Chembio&#8217;s Board of Directors. \u201cGiven David\u2019s extensive network and experience in the industry, he will add valuable insight to help maximize the value of our DPP platform in the market. We look forward to his collaboration and contributions. We also would like to thank Dr. Polan for her service and leadership throughout her tenure and wish her well in her future endeavors.\u201d<\/p>\n<p align=\"left\">\u201cI am excited about the opportunity to work with the Chembio team because they have an advanced point-of-care technology and a tremendous opportunity to provide value across decentralized settings in the healthcare landscape,\u201d said Mr. Bespalko. \u201cI am thrilled to join an organization whose mission aligns with my background, focused on expanding and scaling operations to enable greater access to diagnostic testing.\u201d<\/p>\n<p align=\"left\">\n        <strong>About the DPP Rapid Test Platform<\/strong><br \/>\n        <br \/>Chembio\u2019s proprietary DPP technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio\u2019s easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.<\/p>\n<p align=\"left\">Chembio\u2019s portfolio of DPP-based point-of-care tests with FDA regulatory approvals include the DPP HIV-Syphilis System (PMA approved), DPP HIV 1\/2 Assay (PMA approved and CLIA waived), DPP Zika IgM System (510(k)), and DPP Ebola Antigen System (EUA). Additionally, DPP-based tests have received regulatory approvals from the World Health Organization, CE-Mark, Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA), and other global organizations, where they aid in the detection and diagnosis of several other critical diseases and conditions.<\/p>\n<p align=\"left\">All DPP tests are developed and manufactured in the United States and are the subject of a range of domestic and global patents and patents pending.<\/p>\n<p align=\"left\">\n        <strong>About Chembio Diagnostics<\/strong><br \/>\n        <br \/>Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio\u2019s extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio\u2019s products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ro1y2mANuwr-6SuhLOBzEh1vNb7bMDXMpBt_BAa61DKP4_CuMFRQVAsa6xQO_A42Fu7HJt6Ondm-bbYhaGAGFQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.chembio.com<\/a>.<\/p>\n<p>\n        <em>DPP is Chembio\u2019s registered trademark, and the Chembio logo is Chembio\u2019s trademark. For convenience, these trademarks appear in this release without \u00ae or \u2122 symbols, but that practice does not mean that Chembio will not assert, to the fullest extent under applicable law, its rights to the trademark.<\/em>\n      <\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Philip Taylor<br \/>Gilmartin Group<br \/>(415) 937-5406<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GmsR4UmyII2jdFWvlfXifiWHEdSvrkfv3V84EaTeOM4GJJ6hzkRAk92L0YxhE4EEasTy4dz-Efv-YIszvTNaAbj4CUFsYjwgf_rRHI80Kws=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investor@chembio.com<\/a>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d16a5140-2430-400c-a89d-8efc95e39187\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) &#8212; Chembio Diagnostics, Inc. (Nasdaq:\u00a0CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company\u2019s Board of Directors, effective upon his election on March 4, 2021. Mr. Bespalko brings over 35 years of leadership experience in the global in vitro diagnostics market. Most recently he was Group Vice President, Global Commercial Operations Specialty Diagnostics Group at Thermo Fisher Scientific, which he joined in 2011 as President of Fisher Healthcare. During his tenure there, Mr. Bespalko held additional roles such as President of the Global Anatomical Pathology Division. Previously, Mr. Bespalko was Corporate Vice President, North America Commercial Operations at Beckman Coulter. His diagnostics career &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-452493","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) &#8212; Chembio Diagnostics, Inc. (Nasdaq:\u00a0CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company\u2019s Board of Directors, effective upon his election on March 4, 2021. Mr. Bespalko brings over 35 years of leadership experience in the global in vitro diagnostics market. Most recently he was Group Vice President, Global Commercial Operations Specialty Diagnostics Group at Thermo Fisher Scientific, which he joined in 2011 as President of Fisher Healthcare. During his tenure there, Mr. Bespalko held additional roles such as President of the Global Anatomical Pathology Division. Previously, Mr. Bespalko was Corporate Vice President, North America Commercial Operations at Beckman Coulter. His diagnostics career &hellip; Continue reading &quot;Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T13:03:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors\",\"datePublished\":\"2021-03-08T13:03:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/\"},\"wordCount\":698,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/\",\"name\":\"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\",\"datePublished\":\"2021-03-08T13:03:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk","og_description":"HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) &#8212; Chembio Diagnostics, Inc. (Nasdaq:\u00a0CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company\u2019s Board of Directors, effective upon his election on March 4, 2021. Mr. Bespalko brings over 35 years of leadership experience in the global in vitro diagnostics market. Most recently he was Group Vice President, Global Commercial Operations Specialty Diagnostics Group at Thermo Fisher Scientific, which he joined in 2011 as President of Fisher Healthcare. During his tenure there, Mr. Bespalko held additional roles such as President of the Global Anatomical Pathology Division. Previously, Mr. Bespalko was Corporate Vice President, North America Commercial Operations at Beckman Coulter. His diagnostics career &hellip; Continue reading \"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-08T13:03:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors","datePublished":"2021-03-08T13:03:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/"},"wordCount":698,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/","name":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=","datePublished":"2021-03-08T13:03:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTg3NyM0MDUyNTk1IzIwMDYxMDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chembio-diagnostics-appoints-industry-leader-david-bespalko-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=452493"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452493\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=452493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=452493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=452493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}